Literature DB >> 12865378

Critically ill patients with severe acute respiratory syndrome.

Robert A Fowler1, Stephen E Lapinsky, David Hallett, Allan S Detsky, William J Sibbald, Arthur S Slutsky, Thomas E Stewart.   

Abstract

CONTEXT: Severe acute respiratory syndrome (SARS) is a newly recognized infectious disease capable of causing severe respiratory failure.
OBJECTIVE: To determine the epidemiological features, course, and outcomes of patients with SARS-related critical illness. DESIGN, SETTING, AND PATIENTS: Retrospective case series of 38 adult patients with SARS-related critical illness admitted to 13 intensive care units (ICUs) in the Toronto area between the onset of the outbreak and April 15, 2003. Data were collected daily during the first 7 days in the ICUs, and patients were followed up for 28 days. MAIN OUTCOME MEASURES: The primary outcome was mortality at 28 days after ICU admission. Secondary outcomes included rate of SARS-related critical illness, number of tertiary care ICUs and staff placed under quarantine, and number of health care workers (HCWs) contracting SARS secondary to ICU-acquired transmission.
RESULTS: Of 196 patients with SARS, 38 (19%) became critically ill, 7 (18%) of whom were HCWs. The median (interquartile range [IQR]) age of the 38 patients was 57.4 (39.0-69.6) years. The median (IQR) duration between initial symptoms and admission to the ICU was 8 (5-10) days. Twenty-nine (76%) required mechanical ventilation and 10 of these (34%) experienced barotrauma. Mortality at 28 days was 13 (34%) of 38 patients and for those requiring mechanical ventilation, mortality was 13 (45%) of 29. Six patients (16%) remained mechanically ventilated at 28 days. Two of these patients had died by 8 weeks' follow-up. Patients who died were more often older, had preexisting diabetes mellitus, and on admission to hospital were more likely to have bilateral radiographic infiltrates. Transmission of SARS in 6 study ICUs led to closure of 73 medical-surgical ICU beds. In 2 university ICUs, 164 HCWs were quarantined and 16 (10%) developed SARS.
CONCLUSIONS: Critical illness was common among patients with SARS. Affected patients had primarily single-organ respiratory failure, and half of mechanically ventilated patients died. The SARS outbreak greatly strained regional critical care resources.

Entities:  

Mesh:

Year:  2003        PMID: 12865378     DOI: 10.1001/jama.290.3.367

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  141 in total

1.  Why SARS will not return: a polemic.

Authors:  Donald E Low
Journal:  CMAJ       Date:  2004-01-06       Impact factor: 8.262

2.  Interpretation of diagnostic laboratory tests for severe acute respiratory syndrome: the Toronto experience.

Authors:  Patrick Tang; Marie Louie; Susan E Richardson; Marek Smieja; Andrew E Simor; Frances Jamieson; Margaret Fearon; Susan M Poutanen; Tony Mazzulli; Raymond Tellier; James Mahony; Mark Loeb; Astrid Petrich; Max Chernesky; Allison McGeer; Donald E Low; Elizabeth Phillips; Steven Jones; Nathalie Bastien; Yan Li; Daryl Dick; Allen Grolla; Lisa Fernando; Timothy F Booth; Bonnie Henry; Anita R Rachlis; Larissa M Matukas; David B Rose; Reena Lovinsky; Sharon Walmsley; Wayne L Gold; Sigmund Krajden
Journal:  CMAJ       Date:  2004-01-06       Impact factor: 8.262

3.  Development of a triage protocol for critical care during an influenza pandemic.

Authors:  Michael D Christian; Laura Hawryluck; Randy S Wax; Tim Cook; Neil M Lazar; Margaret S Herridge; Matthew P Muller; Douglas R Gowans; Wendy Fortier; Frederick M Burkle
Journal:  CMAJ       Date:  2006-11-21       Impact factor: 8.262

4.  Expanding ICU facilities in an epidemic: recommendations based on experience from the SARS epidemic in Hong Kong and Singapore.

Authors:  Charles D Gomersall; Dessmon Y H Tai; Shi Loo; James L Derrick; Mia Siang Goh; Thomas A Buckley; Catherine Chua; Ka Man Ho; Geeta P Raghavan; Oi Man Ho; Lay Beng Lee; Gavin M Joynt
Journal:  Intensive Care Med       Date:  2006-03-29       Impact factor: 17.440

5.  Severe acute respiratory syndrome: What have we learned two years later?

Authors:  Lynn B Johnston; John M Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2004-11       Impact factor: 2.471

6.  Use of drotrecogin alfa (activated) in a severe acute respiratory syndrome patient with severe sepsis.

Authors:  Donna McRitchie; Warda Farooq; Harold N Fisher
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-05       Impact factor: 2.471

Review 7.  Current understanding of middle east respiratory syndrome coronavirus infection in human and animal models.

Authors:  Yanqun Wang; Jing Sun; Airu Zhu; Jingxian Zhao; Jincun Zhao
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

8.  Methods for estimating the case fatality ratio for a novel, emerging infectious disease.

Authors:  A C Ghani; C A Donnelly; D R Cox; J T Griffin; C Fraser; T H Lam; L M Ho; W S Chan; R M Anderson; A J Hedley; G M Leung
Journal:  Am J Epidemiol       Date:  2005-08-02       Impact factor: 4.897

9.  A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan.

Authors:  Eric H Y Lau; C Agnes Hsiung; Benjamin J Cowling; Chang-Hsun Chen; Lai-Ming Ho; Thomas Tsang; Chiu-Wen Chang; Christl A Donnelly; Gabriel M Leung
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

10.  The ongoing H1N1 flu pandemic and the intensive care community: challenges, opportunities, and the duties of scientific societies and intensivists.

Authors:  Rui P Moreno; Andrew Rhodes; Jean-Daniel Chiche
Journal:  Intensive Care Med       Date:  2009-10-20       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.